KANNALIFE

Kannalife Sciences, a subsidiary of Neuropathix, Inc., is a biopharmaceutical company focused on the research and development of a pipeline of next generation breakthough therapeutics targeting inflammation to treat patients with significant unmet medical needs... Kannalife, a subsidiary of Neuropathix, Inc, is a biopharmaceutical company focused on discovering, developing and commercializing a product platform of novel molecules from our proprietary next generation cannabinoid therapeutics as potent, non-opioid alternatives to treat patients with a variety of unmet medical needs. Since 2010, we have been principally involved in the research and development of synthetic cannabidiol ("CBD") therapeutics through pre-clinical drug discovery and development processes. We have developed our own intellectual property portfolio and established relationships with globally recognized third parties who are considered leaders in active pharmaceutical ("API") contract manufacturers, formulators..

Also known as: Kannalife Sciences, Kannalife Sciences, Inc., Kannalife, Inc.

Primary location: Doylestown United States